GPR55 and metabolic dysfunction-associated steatotic liver disease: This work provides provocative new evidence that activation of the LPI-GPR55 system is associated with human NAFLD progression in a strikingly similar manner to that seen with Mboat7 deficiency (i.e., a condition where LPI lipids accumulate) (37, 38, 39, 40, 41).